A polêmica sobre o aumento do risco de câncer de mama associado à reposição hormonal na menopausa não termina tão cedo

Luca, Laurival A. de.
Rev. bras. mastologia ; 14(3): 89-90, jul.-set. 2004.
Artigo em Português | LILACS | ID: lil-410621

Documentos relacionados

  1. Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk.
  2. Use of hormone therapy for menopausal symptoms and quality of life in breast cancer survivors. Safe and ethical?
  3. Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.
  4. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
  5. Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
  6. The association between menopausal hormone therapy and breast cancer remains unsettled.
  7. Impact of menopausal hormone therapy on colorectal cancer risk-A systematic review.
  8. Message from the Editor-in-Chief.
  9. A clinical model for identifying the short-term risk of breast cancer.
  10. Menopause hormone treatment after cancer.